Long noncoding RNAs (lncRNAs) have emerged as critical regulators of tumorigenesis and yet their mechanistic role remains challenging to characterize. Here, we present LncRNA Interpreter, a pipeline integrating functional proteomics with interacting proteins to characterize lncRNAs. Its robustness is exemplified by lncRNA Urothelial Cancer Associated 1 (UCA1), a driver of ovarian cancer development. Reverse phase protein array (RPPA) analysis indicates that UCA1 activates Hippo-YAP signaling and in vivo RNA antisense purification (iRAP) of UCA1 interacting proteins identified angiomotin (AMOT), a known YAP regulator, as direct binding partner. Loss-of-function experiments show that AMOT mediates Hippo-YAP signaling activation by UCA1. UCA1 enhances the AMOT-YAP interaction to prevent YAP phosphorylation and facilitate its nuclear translocation. Together, our LncRNA Interpreter pipeline identified UCA1 as an lncRNA regulator of the Hippo-YAP signaling and highlighted the UCA1-AMOT-YAP signaling axis in ovarian cancer development. LncRNA Interpreter can readily be applied to other lncRNAs implicated in complex diseases.
Lin, Xianzhi and Spindler, Tassja J. and Fonseca, Marcos Abraão de Souza and Corona, Rosario I. and Seo, Ji-Heui and Dezem, Felipe Segato and Li, Lewyn and Lee, Janet M. and Long, Henry W. and Sellers, Thomas A. and Karlan, Beth Y. and Noushmehr, Houtan and Freedman, Matthew L. and Gayther, Simon A. and Lawrenson, Kate, LncRNA Interpreter: A Protein-Centric Pipeline for Mechanistic Analysis of Long Noncoding RNAs (October 23, 2018). Available at SSRN: https://ssrn.com/abstract=3271630 or http://dx.doi.org/10.2139/ssrn.3271630
This version of the paper has not been formally peer reviewed.
Subscribe to this free journal for more curated articles on this topic
FOLLOWERS
20
PAPERS
9,210
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.